Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies.

Cookies policy

Data selected by 125 Name Thiafeline

Original name

Strength

Marketing authorisation number

Marketing authorisation holder:

ATCvet code

Species

Thiafeline

5 mg

V/DCP/13/0024

Le Vet Beheer B.V., Nīderlande

QH03BB02

cats

Vairāk

Medicinal product information

Pharmaceutical form:	tablets
International name (active substance):	Thiamazol
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal:	27-Feb-2019
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	DCP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Apr-2025)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Apr-2025)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (22-Apr-2025)

ID	Strength	Package size	Primary packaging	Labelling
V/DCP/13/0024-01	5 mg	1	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0024-02	5 mg	2	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0024-03	5 mg	4	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0024-04	5 mg	5	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0024-05	5 mg	10	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-

Thiafeline

2.5 mg

V/DCP/13/0025

Le Vet Beheer B.V., Nīderlande

QH03BB02

cats

Pharmaceutical form:	tablets
International name (active substance):	Thiamazol
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal:	27-Feb-2019
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	DCP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Apr-2025)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2019)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (22-Apr-2025)

ID	Strength	Package size	Primary packaging	Labelling
V/DCP/13/0025-01	2,5 mg	1	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0025-02	2,5 mg	2	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0025-03	2,5 mg	4	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0025-04	2,5 mg	5	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-
V/DCP/13/0025-05	2,5 mg	10	PVH/Al blisteris (necaurspīdīgs), 30 tablete	-

2 records · Download